Results 51 to 60 of about 303,632 (262)

Decrease in JAK2V617F allele burden is not a prerequisite to clinical response in patients with polycythemia vera

open access: yesHaematologica, 2012
Background Although reduction in the JAK2V617F allele burden (%V617F) has been suggested as a criterion for defining disease response to cytoreductive therapy in polycythemia vera, its value as a response monitor is unclear.
Emil Kuriakose   +7 more
doaj   +1 more source

Givinostat: an emerging treatment for polycythemia vera

open access: yesExpert Opinion on Investigational Drugs, 2020
Introduction Polycythemia vera (PV), a Philadelphia chromosome-negative myeloproliferative neoplasm, is characterized by panmyelosis, pancytosis, and a JAK2 mutation.
H. Chifotides, P. Bose, S. Verstovsek
semanticscholar   +1 more source

Preleukemia: hematological disorders prior to onset of leukemia [PDF]

open access: yes, 1975
Published data on Japanese leukemia patients with a preleukemic hematological disorder were assessed. The reexamined cases were from the "Japona Centra Revuo Medicina" reported during the period from 1952 to 1971.
Hiraki, Kiyoshi   +5 more
core   +1 more source

Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study

open access: yesLeukemia, 2020
Rambaldi, A., Iurlo, A., Vannucchi, A. M., Noble, R., von Bubnoff, N., Guarini, A., Martino, B., Pezzutto, A., Carli, G., De Muro, M., Luciani, S., McMullin, M. F., Cambier, N., Marolleau, J-P., Mesa, R. A., Tibes, R., Pancrazzi, A., Gesullo, F., Bettica,
A. Rambaldi   +20 more
semanticscholar   +1 more source

Polycythemia vera masked due to severe iron deficiency anemia

open access: yesHematology/Oncology and Stem Cell Therapy, 2018
Polycythemia vera is one of the chronic myeloproliferative diseases and very few patients present with its actual clinical manifestations. The most common findings are increased red cell mass and an increased leukocyte count with decreased erythropoietin.
Shweta Kambali, Asma Taj
doaj   +1 more source

The utility of testing erythropoietin level in polycythemia diagnosis

open access: yesHematology, 2023
Objectives: Polycythemia vera (PV) is classically thought to be associated with low erythropoietin (EPO) levels. Here, we present a review of the utility of using EPO levels in diagnosing polycythemia.Methods: We conducted a systematic literature review ...
Abdellatif Ismail   +7 more
doaj   +1 more source

Novel superhydrophobic and superoleophilic sugarcane green ceramic hollow fibre membrane as hybrid oil sorbent-separator of real oil and water mixture [PDF]

open access: yes, 2018
The frequent oil spill accidents in nowadays has aroused great attention all over the world. Superhydrophobic and superoleophilic grafted on various substrates have attracted much attention to treat oil and water mixture because of their unique ...
Harun, Zawati   +4 more
core   +1 more source

Pegylated Interferon Alfa-2a for Polycythemia Vera or Essential Thrombocythemia Resistant or Intolerant to Hydroxyurea.

open access: yesBlood, 2019
Prior studies have reported high response rates with recombinant interferon-α (rIFN-α) therapy in patients with essential thrombocythemia (ET) and polycythemia vera (PV).
A. Yacoub   +33 more
semanticscholar   +1 more source

Polycythemia vera as a presentation of renal angiomyolipoma: a case report

open access: yesJournal of Medical Case Reports, 2009
Introduction Angiomyolipoma is a common benign renal tumor composed of thick-walled blood vessels, smooth muscle, and adipose tissue. It may be found incidentally during workup for suspected renal disease.
Lin Ming-Shyan   +7 more
doaj   +1 more source

Leukocytosis and thrombosis in essential thrombocythemia and polycythemia vera: a systematic review and meta-analysis.

open access: yesBlood Advances, 2019
In the last years, a growing amount of evidence has been produced regarding the role of leukocytosis as a risk factor for thrombosis in patients with myeloproliferative neoplasms, predominantly in polycythemia vera (PV) and essential thrombocythemia (ET).
A. Carobbio   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy